44.48
-4.46
(-9.11%)
As of 12:11:26 PM GMT+5:30. Market Open.
Loading Chart for PARMAX.BO
- Previous Close
48.94 - Open
42.95 - Bid 43.11 x --
- Ask 44.45 x --
- Day's Range
42.95 - 45.72 - 52 Week Range
36.20 - 50.90 - Volume
1,200 - Avg. Volume
790 - Market Cap (intraday)
166.413M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: PARMAX.BO
View MorePerformance Overview: PARMAX.BO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
PARMAX.BO
0.52%
S&P BSE SENSEX (^BSESN)
1.69%
1-Year Return
PARMAX.BO
4.61%
S&P BSE SENSEX (^BSESN)
4.65%
3-Year Return
PARMAX.BO
4.61%
S&P BSE SENSEX (^BSESN)
31.67%
5-Year Return
PARMAX.BO
4.61%
S&P BSE SENSEX (^BSESN)
152.85%
Compare To: PARMAX.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
44.48
-9.11%
Mkt Cap INR 166.413M
Industry Drug Manufacturers—Specialty & Generic
143.05
+1.24%
Mkt Cap INR 1.466B
Industry Drug Manufacturers—Specialty & Generic
71.25
-2.26%
Mkt Cap INR 730.655M
Industry Drug Manufacturers—Specialty & Generic
175.15
+1.92%
Mkt Cap INR 8.777B
Industry Drug Manufacturers—Specialty & Generic
147.50
+0.37%
Mkt Cap INR 1.943B
Industry Drug Manufacturers—Specialty & Generic
215.00
+1.42%
Mkt Cap INR 2.223B
Industry Drug Manufacturers—Specialty & Generic
413.45
-1.34%
Mkt Cap INR 50.979B
Industry Drug Manufacturers—Specialty & Generic
641.50
+1.79%
Mkt Cap INR 2.292B
Industry Drug Manufacturers—Specialty & Generic
695.45
+2.45%
Mkt Cap INR 63.032B
Industry Drug Manufacturers—Specialty & Generic
616.50
+6.45%
Mkt Cap INR 19.471B
Industry Drug Manufacturers—Specialty & Generic
2,000.00
+1.57%
Mkt Cap INR 913.13B
Industry Drug Manufacturers—Specialty & Generic
Statistics: PARMAX.BO
View MoreValuation Measures
As of 4/11/2025
Market Cap
183.10M
Enterprise Value
239.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.66
Price/Book (mrq)
--
Enterprise Value/Revenue
0.87
Enterprise Value/EBITDA
332.48
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: PARMAX.BO
View MoreCompany Insights: PARMAX.BO
Research Reports: PARMAX.BO
View MorePeople Also Watch
PARNAXLAB.BO Parnax Lab Limited
100.05
0.00%
ISHITADR.BO Ishita Drugs and Industries Limited
80.10
-2.67%
SANDUPHQ.BO Sandu Pharmaceuticals Limited
48.04
0.00%
SHUKRAPHAR.BO Shukra Pharmaceuticals Limited
19.55
+4.99%
MERCURYLAB.BO Mercury Laboratories Limited
823.80
0.00%
PANCHSHEEL.BO Panchsheel Organics Limited
147.50
+0.37%
CONCORD.BO Concord Drugs Limited
31.00
-0.95%
SUNLOC.BO Sunil Healthcare Limited
71.25
-2.26%
PHARMAID.BO Pharmaids Pharmaceuticals Limited
67.47
+3.01%
SYSCHEM.BO Syschem (India) Limited
40.99
+5.37%
VEERHEALTH.BO Veerhealth Care Limited
14.93
+4.19%
UNJHAFOR.BO Unjha Formulations Limited
23.00
+3.98%
COLINZ.BO Colinz Laboratories Limited
50.48
+4.99%
GODAVARI.BO Godavari Drugs Limited
96.83
+3.54%
DENISCHEM.BO Denis Chem Lab Limited
96.70
+2.50%
SMRUTHIORG.BO Smruthi Organics Limited
116.45
0.00%